TY - JOUR
T1 - Metabolic Syndrome and Diabetes Mellitus in Mexico
T2 - the Role of PET/CT in Endothelial Dysfunction and Cardiovascular Disease Detection
AU - Rosas, Erick Alexánderson
AU - Castro, Jonathan Badin
AU - Anaya, Diego Adrián Vences
AU - del Moral Díez, Juan José
AU - Bueso, Jessy Steve Masso
AU - Niño, Alejandro Jiménez
AU - Germán, Ana Gabriela Ayala
AU - Rodríguez, Erick Donato Morales
AU - Sánchez, Carlos Alberto Guízar
AU - González, Aloha Meave
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Abstract: Purpose of Review: Metabolic syndrome (MetS) and diabetes mellitus (DM) have become over the past years a global burden of disease. They are one of the main risk factors for cardiovascular disease among others. CVDs represent the number one cause of death globally. Diabetes Mellitus’ prevalence, especially type 2, has increased dramatically in a short period increasing health care costs and mortality worldwide. Detecting coronary artery disease in diabetic patients with a myocardial perfusion imaging method such as PET/CT is the primary concern for this review. Recent Findings: The most recent survey in Mexico done in 2012 reveals that an overall prevalence of 9.4% of the population has DM, which is roughly 6.4 million people with DM. Myocardial perfusion imaging with PET/CT has proven to be an accurate method to assess myocardial perfusion defects and viability in both symptomatic and asymptomatic patients with DM. Summary: In this review, we briefly describe the latest data on DM in Mexico and the use of MPI with PET/CT for patients with this disease, creating a discussion of the use of this technique as a screening method for endothelial dysfunction to prevent cardiovascular outcomes.
AB - Abstract: Purpose of Review: Metabolic syndrome (MetS) and diabetes mellitus (DM) have become over the past years a global burden of disease. They are one of the main risk factors for cardiovascular disease among others. CVDs represent the number one cause of death globally. Diabetes Mellitus’ prevalence, especially type 2, has increased dramatically in a short period increasing health care costs and mortality worldwide. Detecting coronary artery disease in diabetic patients with a myocardial perfusion imaging method such as PET/CT is the primary concern for this review. Recent Findings: The most recent survey in Mexico done in 2012 reveals that an overall prevalence of 9.4% of the population has DM, which is roughly 6.4 million people with DM. Myocardial perfusion imaging with PET/CT has proven to be an accurate method to assess myocardial perfusion defects and viability in both symptomatic and asymptomatic patients with DM. Summary: In this review, we briefly describe the latest data on DM in Mexico and the use of MPI with PET/CT for patients with this disease, creating a discussion of the use of this technique as a screening method for endothelial dysfunction to prevent cardiovascular outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85013140554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013140554&partnerID=8YFLogxK
U2 - 10.1007/s12410-017-9404-6
DO - 10.1007/s12410-017-9404-6
M3 - Review article
AN - SCOPUS:85013140554
SN - 1941-9066
VL - 10
JO - Current Cardiovascular Imaging Reports
JF - Current Cardiovascular Imaging Reports
IS - 3
M1 - 7
ER -
